Femme Medical

Treatment for Pelvic Organ Prolapse

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2021 by Yehuda Bachar, Adrian Paz, and Mr Tovy, Femme Medical operates with 1–10 employees. The company secured a grant from the Israel Innovation Authority in January 2024.

Business overview

Femme Medical is a Health Tech & Life Sciences company focused on developing a non-surgical, permanent solution for women suffering from pelvic organ prolapse. The company's core technology addresses a significant need in women's health, operating within the medical devices sector and targeting consumers, particularly women, as well as healthcare providers.

Strategic signal

In January 2024, Femme Medical secured a grant from the Israel Innovation Authority. This funding validates the potential of their non-surgical solution for pelvic organ prolapse, signaling strong institutional confidence in their R&D efforts and future market impact within the women's health and medical devices sectors.

Company Intelligence Q&A

When was Femme Medical founded?
Femme Medical was founded in January 2021.
Who are the founders of Femme Medical?
Femme Medical was founded by Yehuda Bachar, Adrian Paz, and Mr Tovy.
What is Femme Medical's primary focus?
Femme Medical is developing a non-surgical, permanent solution for women with pelvic organ prolapse.
What significant funding did Femme Medical receive?
In January 2024, Femme Medical secured a grant from the Israel Innovation Authority.
What is the current employee count for Femme Medical?
Femme Medical currently has 1–10 employees.